Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,409,667
-$75,034 QoQ
Shares Held
58,541
+10.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,118
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TWIN CAPITAL MANAGEMENT INC holds $51,361,248 across 9 Drug Manufacturers - General names. PFE ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,076 | $18,082,608 | |
| 2 | JNJ |
Johnson & Johnson
|
47,173 | $11,980,526 | |
| 3 | AMGN |
Amgen Inc
|
15,782 | $5,714,977 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,649 | $5,223,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
80,607 | $4,644,575 | |
| 6 | ABBV |
AbbVie Inc.
|
11,313 | $2,846,803 | |
| 7 | PFE |
Pfizer Inc
This page
|
58,541 | $1,409,667 | |
| 8 | BIIB |
Biogen Inc.
|
4,465 | $964,707 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,409,667 | 58,541 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,484,701 | 52,874 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,408,601 | 96,731 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,318,807 | 91,005 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,247,702 | 92,727 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,687,872 | 66,609 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,789,130 | 67,438 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,964,562 | 67,884 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $578,962 | 20,692 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $579,753 | 20,892 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,793,168 | 131,753 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $4,489,360 | 135,344 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,814,176 | 131,248 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $4,842,837 | 118,697 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $8,285,046 | 161,691 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $7,179,571 | 164,067 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $8,631,655 | 164,632 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $8,625,037 | 166,603 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $10,726,904 | 181,658 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $7,254,625 | 168,673 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $6,797,901 | 173,593 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $5,911,033 | 163,153 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $6,481,247 | 176,073 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $6,709,487 | 182,820 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $5,942,250 | 181,720 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $7,549,328 | 231,291 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||